Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Wiad Lek ; 52(11-12): 563-8, 1999.
Artículo en Polaco | MEDLINE | ID: mdl-10745692

RESUMEN

In this paper the evaluation of midazolam (Dormicum) efficiency in obtaining basic sedative effect in 36 children during diagnostic examinations and short surgical operations was done. In 26 patients good sedative effect was obtained. Forgetfulness was present in 17 from 25 patients above 2 years of life, and partial in the rest 8 patients. Fear reactions were observed in 10 children with lower doses of this medicine. Side effects were observed in 8 patients, and had a transient character and were not dangerous for the patients' life.


Asunto(s)
Servicios de Diagnóstico , Hipnóticos y Sedantes/administración & dosificación , Midazolam/administración & dosificación , Procedimientos Quirúrgicos Operativos/métodos , Adolescente , Niño , Preescolar , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Masculino , Factores de Tiempo
2.
Wiad Lek ; 51(7-8): 378-82, 1998.
Artículo en Polaco | MEDLINE | ID: mdl-9748895

RESUMEN

Diagnostic and therapeutic problems in the course of tuberculosis in a 4 year old boy were described. First symptoms of disease such as specific inflammation of lymph nodes were observed in THE third month of liFe. After typical antituberculous treatment the signs of disease regressed. In consequence of the contact with an individual expeCtorating tubercle bacilli superinfection and generalization of the disease took place what led to the boy's death.


Asunto(s)
Antituberculosos/uso terapéutico , Isoniazida/uso terapéutico , Rifampin/uso terapéutico , Tuberculosis/diagnóstico , Tuberculosis/tratamiento farmacológico , Preescolar , Resultado Fatal , Humanos , Masculino
3.
Pediatr Pol ; 70(11): 925-8, 1995 Nov.
Artículo en Polaco | MEDLINE | ID: mdl-8677158

RESUMEN

Clinical studies of antiemetic treatment with Zofran in children suffering from neoplastic diseases are presented. The studies were carried out in 33 children aged 3 months to 17 years treated in 1993. The majority of the patients were treated for ALL (20), Hodgkins disease (3), nephroblastoma (3), non-Hodgkin lymphoma (2), solid tumors (5). Two-hundred thirty-eight cycles of chemotherapy with cystostatics having varied emetic effects were carried out in these children. Zofran was given in one dose, one hour before chemotherapy in a dose of 4 or 8 mg. The intensity of vomiting was assessed according to the WHO 5-grade scale. O to 1 grade of vomiting was observed in 84.4%, 2nd grade in 15.2%. There were no cases of 3rd or 4th grade vomiting. No side-effects of the medication were observed in the studied group. It was found that Zofran is an effective and well-tolerated antiemetic medication in children on chemotherapy.


Asunto(s)
Antieméticos/uso terapéutico , Neoplasias/complicaciones , Ondansetrón/uso terapéutico , Vómitos/tratamiento farmacológico , Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Vómitos/etiología
4.
Pediatr Pol ; 70(5): 395-9, 1995 May.
Artículo en Polaco | MEDLINE | ID: mdl-8692593

RESUMEN

The efficacy of 3 schemes of passive and active prevention of HBV infection was evaluated in 47 children with haematologic proliferative diseases. Twenty-six children suffering from leukemia (group I) received passive immunisation (hepatitis B immunoglobulin) in six week intervals during intensive chemotherapy and were vaccinated on maintenance therapy. Thirteen children with Hodgkin or B-non-Hodgkin lymphoma (group II) received active immunisation from the beginning of intensive chemotherapy with two doses of immunoglobulin. Eight children who had completed their therapy (group III) were vaccinated only. Among children who completed vaccinations, 5/8 in group I, 4/7 in group II and 5/5 in group III produced protective anti-HBs levels. Passive/active prophylaxis was successful in most patients suffering from neoplastic diseases and reduced the endemy of HBV infection in our department from 43.3% to 2.56% infected subjects. Among 7 patients vaccinated from the beginning of treatment (group II), 4 of them produced protective levels of anti,-HBs, despite intensive chemotherapy.


Asunto(s)
Vacunas contra Hepatitis B/uso terapéutico , Hepatitis B/prevención & control , Inmunización Pasiva , Leucemia , Vacunación , Adolescente , Niño , Preescolar , Femenino , Humanos , Masculino
5.
Pediatr Pol ; 70(3): 213-8, 1995 Mar.
Artículo en Polaco | MEDLINE | ID: mdl-8657488

RESUMEN

A safe and effective method of venous access is important in the care and treatment of patients with malignancies. Thirty-seven Broviac-Hickman catheters were inserted in 32 children with haematological neoplastic disease. The mean indwelling time of the catheters was 7014 days. The catheters were used to administer chemotherapy and other drugs, blood products, and as well as to draw blood. Fever occurred 96 times. Forty-three percent of fever episodes were related to clinically documented infections and in 15% of cases, to catheter-related bacteremia caused by Gram-positive and Gram-negative strains in equivalent proportions. Fever was observed with a two fold greater incidence in patients with severe granulocytopenia (< 0.5 G/l).


Asunto(s)
Cateterismo Venoso Central/efectos adversos , Fiebre/etiología , Leucemia Mieloide Aguda/complicaciones , Linfoma no Hodgkin/complicaciones , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Adolescente , Agranulocitosis/etiología , Infecciones Bacterianas/etiología , Catéteres de Permanencia/efectos adversos , Niño , Preescolar , Humanos , Leucemia Mieloide Aguda/terapia , Linfoma no Hodgkin/terapia , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA